MYRIAH MCCABE: Open Payments
NPI 1225817844 · TEANECK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$743 in 54 payments from 10 companies in 2025. Trend: 2023 $72 · 2024 $957 · 2025 $743
Food & beverage: $743
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $248 |
| PFIZER INC. | 10 | $170 |
| UCB, Inc. | 6 | $121 |
| Lilly USA, LLC | 3 | $50 |
| MDD US Operations, LLC | 2 | $35 |
| Neurelis, Inc. | 2 | $35 |
| Teva Pharmaceuticals USA, Inc. | 2 | $33 |
| Lundbeck LLC | 1 | $18 |
| SK Life Science, Inc. | 1 | $17 |
| Amneal Pharmaceuticals LLC | 1 | $16 |
Products named: NURTEC ODT, QULIPTA, Nayzilam, UBRELVY, KISUNLA, BOTOX, Rystiggo, VALTOCO.
Industry payments across NJ — which companies pay providers there.
